1
|
Effects of a selective cyclo-oxygenase 2 inhibitor on colonic anastomotic and skin wound integrity.
|
Br J Surg
|
2004
|
1.68
|
2
|
Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer.
|
Br J Surg
|
2003
|
1.46
|
3
|
Replication error phenotype, clinicopathological variables, and patient outcome in Dukes' B stage II (T3,N0,M0) colorectal cancer.
|
Gut
|
2000
|
1.21
|
4
|
Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer.
|
J Pathol
|
2006
|
1.17
|
5
|
Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transition.
|
Oncogene
|
2007
|
1.15
|
6
|
Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer.
|
Gut
|
2010
|
1.08
|
7
|
Proliferation indexes--a comparison between cutaneous basal and squamous cell carcinomas.
|
J Clin Pathol
|
1996
|
1.08
|
8
|
The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
|
Colorectal Dis
|
2014
|
1.08
|
9
|
Formalin-fixed paraffin-embedded clinical tissues show spurious copy number changes in array-CGH profiles.
|
Clin Genet
|
2007
|
1.02
|
10
|
The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study.
|
Br J Cancer
|
2011
|
0.97
|
11
|
The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue.
|
Br J Cancer
|
2011
|
0.97
|
12
|
CD44V6 in gastric carcinoma: a marker of tumor progression.
|
Appl Immunohistochem Mol Morphol
|
2001
|
0.96
|
13
|
Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicity.
|
Fam Cancer
|
2013
|
0.93
|
14
|
Maintenance versus reduction of immunosuppression in renal transplant recipients with aggressive squamous cell carcinoma.
|
Dermatol Surg
|
2004
|
0.90
|
15
|
Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling.
|
Oncogene
|
2012
|
0.87
|
16
|
Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer.
|
Br J Cancer
|
2009
|
0.86
|
17
|
Acute and chronic bioeffects of single and multiple doses of piezoelectric shockwaves (EDAP LT.01).
|
J Urol
|
1991
|
0.86
|
18
|
Apoptosome-dependent caspase activation proteins as prognostic markers in Stage II and III colorectal cancer.
|
Br J Cancer
|
2012
|
0.86
|
19
|
Soft tissue and visceral sarcomas in Irish patients. Interim analysis of data obtained by the Dublin Soft Tissue Tumour Panel.
|
Ir J Med Sci
|
1994
|
0.85
|
20
|
Association between cyclooxygenase-2-expressing macrophages, ulceration and microvessel density in colorectal cancer.
|
Histopathology
|
2005
|
0.84
|
21
|
Poor agreement in recognition of abnormal mitoses: requirement for standardized and robust definitions.
|
Histopathology
|
2001
|
0.84
|
22
|
p53 codon 72 polymorphism and human papillomavirus associated skin cancer.
|
J Clin Pathol
|
2001
|
0.84
|
23
|
Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival.
|
Br J Cancer
|
2006
|
0.83
|
24
|
ras and p53 in the prediction of survival in Dukes' stage B colorectal carcinoma.
|
Clin Mol Pathol
|
1995
|
0.83
|
25
|
Primary lymphoma of the bladder: a report of three cases.
|
Ir J Med Sci
|
2002
|
0.83
|
26
|
Identification of vertical growth phase in malignant melanoma. A study of interobserver agreement.
|
Am J Clin Pathol
|
1998
|
0.82
|
27
|
Bleeding due to colorectal atheroembolism. Diagnosis by biopsy of adenomatous polyps or of ischemic ulcer.
|
Am J Surg Pathol
|
1991
|
0.82
|
28
|
Deletion of the FHIT gene in neoplastic and invasive cervical lesions is related to high-risk HPV infection but is independent of histopathological features.
|
J Pathol
|
2000
|
0.81
|
29
|
Aberrant DNA methylation associated with MTHFR C677T genetic polymorphism in cutaneous squamous cell carcinoma in renal transplant patients.
|
Br J Dermatol
|
2010
|
0.81
|
30
|
Low-dose retinoid therapy for chemoprophylaxis of skin cancer in renal transplant recipients.
|
J Eur Acad Dermatol Venereol
|
1998
|
0.81
|
31
|
Porphyrin metabolism in hepatitis C infection.
|
Photodermatol Photoimmunol Photomed
|
1996
|
0.81
|
32
|
Cyclooxygenase-2 expression in primary human colorectal cancers and bone marrow micrometastases.
|
Dig Liver Dis
|
2004
|
0.80
|
33
|
The impact of the organ retention controversy on the practice of hospital necropsy: a four year audit.
|
J Clin Pathol
|
2004
|
0.80
|
34
|
Adenocarcinoma arising in a retrorectal teratoma: case report and review of the literature.
|
Colorectal Dis
|
2011
|
0.80
|
35
|
Has the ThinPrep method of cervical screening maintained its improvement over conventional smears in terms of specimen adequacy?
|
Diagn Cytopathol
|
2009
|
0.79
|
36
|
Well differentiated fetal adenocarcinoma of the lung in a 29 year old woman.
|
J Clin Pathol
|
2003
|
0.79
|
37
|
Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome.
|
J Pathol
|
2000
|
0.79
|
38
|
Screening of patients with iron overload to identify hemochromatosis and porphyria cutanea tarda.
|
Arch Dermatol
|
1997
|
0.78
|
39
|
Autoimmune chronic active hepatitis associated with the presence of antiphospholipid antibodies.
|
Eur J Gastroenterol Hepatol
|
1998
|
0.77
|
40
|
An Irish biobank network for patient-focused research.
|
Ir Med J
|
2011
|
0.77
|
41
|
A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb.
|
Mol Pathol
|
2001
|
0.77
|
42
|
Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy.
|
J Eur Acad Dermatol Venereol
|
1998
|
0.77
|
43
|
BCL2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancer.
|
J Mol Med (Berl)
|
2014
|
0.76
|
44
|
p53 tumor suppressor gene protein expression in premalignant and malignant skin lesions of kidney transplant recipients.
|
J Am Acad Dermatol
|
1997
|
0.76
|
45
|
Altered expression of the p53-regulated proteins, p21Waf1/Cip1, MDM2, and Bax in ultraviolet-irradiated human skin.
|
Hum Pathol
|
1998
|
0.76
|
46
|
An audit of cervical cytology smear results reported as "dyskaryosis, difficult to grade; colposcopy advised".
|
Diagn Cytopathol
|
2009
|
0.75
|
47
|
Malacoplakia of transplant ureter resulting in anuric renal failure.
|
J Urol
|
1999
|
0.75
|
48
|
Renal cell carcinoma presenting as a pseudo-carcinoid tumour.
|
Eur J Gastroenterol Hepatol
|
1999
|
0.75
|
49
|
Altered p53 expression in benign and malignant skin lesions from renal transplant recipients and immunocompetent patients with skin cancer: correlation with human papillomaviruses?
|
Diagn Mol Pathol
|
2001
|
0.75
|
50
|
The pathology of cervical cancer.
|
Clin Obstet Gynecol
|
1995
|
0.75
|
51
|
Survival and progression in high grade tumour subset of G2 and G3 pT1 bladder transitional cell carcinoma.
|
Eur J Surg Oncol
|
2006
|
0.75
|
52
|
Malignant melanoma in transplant patients: review of five cases.
|
Clin Exp Dermatol
|
2006
|
0.75
|
53
|
The effect of thermal preconditioning of the limb on flexor tendon healing.
|
J Hand Surg Eur Vol
|
2007
|
0.75
|
54
|
Ploidy profile of morphologically normal squamous epithelium adjacent to high grade cervical intraepithelial neoplasia.
|
Br J Obstet Gynaecol
|
1997
|
0.75
|
55
|
Heterotopic ossification following biopsy--a sheep in wolf's clothing.
|
Histopathology
|
1997
|
0.75
|
56
|
Catecholamine secretion and ploidy in phaeochromocytoma.
|
Int J Clin Pract
|
2000
|
0.75
|
57
|
Evaluation of p53 protein expression in renal cell carcinoma: comparison of two antibodies.
|
Br J Biomed Sci
|
1996
|
0.75
|
58
|
The evaluation of trials of medical therapy. A didactic guide to nonsense detection.
|
Ir J Med Sci
|
1985
|
0.75
|
59
|
Post-menopausal ureteric endometriosis.
|
Br J Urol
|
1988
|
0.75
|
60
|
p53 mutations in squamous cell carcinomas from renal transplant recipients.
|
Biochem Soc Trans
|
1997
|
0.75
|